FDA Accepts Supplement for DATSCAN (NDA022454) by GE Healthcare
The FDA has accepted a supplemental application for DATSCAN (NDA022454) from GE Healthcare.
Asset / Drug
Drug and asset intelligence for DATSCAN with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.